News
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
India is the largest supplier of generic drugs, accounting for about 20% of the global supply. It manufactures about 60,000 ...
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
11h
Inquirer.net on MSNDOH to public: Save more by buying generic medicinesThe Department of Health (DOH) on Wednesday encouraged the public to buy more generic medicines as it announced that the ...
11h
NDTV Profit on MSNHyderabad-based Granules recalls over 33,000 bottles of blood lowering medicationThe drug-maker is recalling India-produced Metoprolol Succinate extended-release tablets in 100 count and 500 count bottles ...
Rising prices stressing you out? Me too. Follow these simple dos and don’ts, and you might become a bulk-buying evangelist ...
Amazon Prime Day 2025 deals on Thunderbolt docks and USB-C hubs are on now! We've rounded up all the best deals from Anker to ...
Simplicity Group's study analyzed over 50,000 data points related to 40 crypto token launches in the first four months of the year.
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...
Inside information: Orion upgrades full-year outlook for 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results